These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 1282868)
1. A clinical guide to antipsychotic drugs. Schwartz JT; Brotman AW Drugs; 1992 Dec; 44(6):981-92. PubMed ID: 1282868 [TBL] [Abstract][Full Text] [Related]
2. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder. Swainston Harrison T; Perry CM Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633 [TBL] [Abstract][Full Text] [Related]
3. Effects of newer antipsychotics on extrapyramidal function. Tarsy D; Baldessarini RJ; Tarazi FI CNS Drugs; 2002; 16(1):23-45. PubMed ID: 11772117 [TBL] [Abstract][Full Text] [Related]
4. Long-acting injectable antipsychotics in the elderly: guidelines for effective use. Masand PS; Gupta S Drugs Aging; 2003; 20(15):1099-110. PubMed ID: 14651433 [TBL] [Abstract][Full Text] [Related]
5. Upcoming agents for the treatment of schizophrenia: mechanism of action, efficacy and tolerability. Bishara D; Taylor D Drugs; 2008; 68(16):2269-92. PubMed ID: 18973393 [TBL] [Abstract][Full Text] [Related]
6. New drugs for schizophrenia: an update for family physicians. Amadio PB; Cross LB; Amadio P Am Fam Physician; 1997 Sep; 56(4):1149-56, 1159-60. PubMed ID: 9310066 [TBL] [Abstract][Full Text] [Related]
7. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. Kane JM; Leucht S; Carpenter D; Docherty JP; J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142 [TBL] [Abstract][Full Text] [Related]
12. Quetiapine : A Review of its Use in Schizophrenia. Gunasekara NS; Spencer CM CNS Drugs; 1998 Apr; 9(4):325-40. PubMed ID: 27521016 [TBL] [Abstract][Full Text] [Related]
13. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. Keefe RS; Seidman LJ; Christensen BK; Hamer RM; Sharma T; Sitskoorn MM; Lewine RR; Yurgelun-Todd DA; Gur RC; Tohen M; Tollefson GD; Sanger TM; Lieberman JA Am J Psychiatry; 2004 Jun; 161(6):985-95. PubMed ID: 15169686 [TBL] [Abstract][Full Text] [Related]
14. Treatment of psychosis in Parkinson's disease: safety considerations. Fernandez HH; Trieschmann ME; Friedman JH Drug Saf; 2003; 26(9):643-59. PubMed ID: 12814332 [TBL] [Abstract][Full Text] [Related]
16. Olanzapine: an updated review of its use in the management of schizophrenia. Bhana N; Foster RH; Olney R; Plosker GL Drugs; 2001; 61(1):111-61. PubMed ID: 11217867 [TBL] [Abstract][Full Text] [Related]
17. The relationship of pharmacology to side effects. Casey DE J Clin Psychiatry; 1997; 58 Suppl 10():55-62. PubMed ID: 9265918 [TBL] [Abstract][Full Text] [Related]
18. Atypical antipsychotics: mechanism of action. Seeman P Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706 [TBL] [Abstract][Full Text] [Related]
19. Analysis of differential clinical profiles of different antipsychotic molecules in the first psychotic episode: a retrospective study. Spanarello S; Beoni AM; Mina G; Amantini K; Colotto A Encephale; 2005; 31(6 Pt 1):692-7. PubMed ID: 16462688 [TBL] [Abstract][Full Text] [Related]
20. Extrapyramidal symptoms are serious side-effects of antipsychotic and other drugs. Blair DT; Dauner A Nurse Pract; 1992 Nov; 17(11):56, 62-4, 67. PubMed ID: 1359485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]